There's a mere nine days to go before a policy kicks in that will require all US agencies to send new regulations and guidance documents to the Office of Management and Budget so it can determine whether they're "major," yet an FDA official says the agency is still foggy on the details.
Beginning on 11 May, rules and guidances must go to the OMB's Office of Information and Regulatory Affairs for review. If the documents are considered by the OIRA to be...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?